Cwm, LLC Biotechnology

Cwm, LLC

$33.3 Billion
Q3 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
BMEA Biomea Fusion, Inc.	$37.2M	$1,000 0.0% of portfolio	364	Q3 2025 Reduced 98.06%
CADL Candel Therapeutics, Inc.	$145M	$1,000 0.0% of portfolio	196	Q3 2025 Reduced 56.83%
CRDF Cardiff Oncology, Inc.	$92.7M	$1,000 0.0% of portfolio	444	Q3 2025 Reduced 35.75%
DMAC Dia Medica Therapeutics Inc.	$157M	$1,000 0.0% of portfolio	86	Q3 2025 New
ETON Eton Pharmaceuticals, Inc.	$428M	$1,000 0.0% of portfolio	31	Q3 2025 New
GALT Galectin Therapeutics Inc	$302M	$1,000 0.0% of portfolio	330	Q3 2025 Reduced 73.79%
GLSI Greenwich Life Sciences, Inc.	$110M	$1,000 0.0% of portfolio	60	Q3 2025 Added 1.69%
INMB Inmune Bio, Inc.	$28.2M	$1,000 0.0% of portfolio	661	Q3 2025 Added 45.92%
NERV Minerva Neurosciences, Inc.	$19.5M	$1,000 0.0% of portfolio	420	Q3 2025 New
MLTX Moon Lake Immunotherapeutics	$393M	$1,000 0.0% of portfolio	142	Q3 2025 Added 18.33%
NRSN Neuro Sense Therapeutics Ltd.	$10.9M	$1,000 0.0% of portfolio	1,000	Q3 2022 New
PLRX Pliant Therapeutics, Inc.	$72.5M	$1,000 0.0% of portfolio	657	Q3 2025 Reduced 80.09%
PYXS Pyxis Oncology, Inc.	$138M	$1,000 0.0% of portfolio	414	Q3 2025 Reduced 93.67%
ABEO Abeona Therapeutics Inc.	$25M	$0 0.0% of portfolio	94	Q3 2025 New
ALXO Alx Oncology Holdings Inc	$50.1M	$0 0.0% of portfolio	144	Q3 2025 Reduced 88.96%
APLT Applied Therapeutics Inc.	$40.8M	$0 0.0% of portfolio	376	Q3 2025 Reduced 93.23%
ATOS Atossa Therapeutics, Inc.	$101M	$0 0.0% of portfolio	225	Q3 2025 Reduced 96.26%
LIFE A Tyr Pharma Inc	$53.2M	$0 0.0% of portfolio	19	Q3 2025 New
CCCC C4 Therapeutics, Inc.	$113M	$0 0.0% of portfolio	146	Q3 2025 Reduced 98.56%
IPSC Century Therapeutics, Inc.	$31.2M	$0 0.0% of portfolio	254	Q3 2025 Reduced 96.88%
ELYM Eliem Therapeutics, Inc.	$109M	$0 0.0% of portfolio	107	Q3 2025 Reduced 95.53%
CRVS Corvus Pharmaceuticals, Inc.	$354M	$0 0.0% of portfolio	57	Q3 2025 New
ELDN Eledon Pharmaceuticals, Inc.	$28.3M	$0 0.0% of portfolio	88	Q3 2025 New
GBIO Generation Bio Co.	$296M	$0 0.0% of portfolio	4	Q3 2025 Reduced 99.94%
JANX Janux Therapeutics, Inc.	$1.1B	$0 0.0% of portfolio	4	Q3 2025 Reduced 96.72%
NAUT Nautilus Biotechnology, Inc.	$177M	$0 0.0% of portfolio	182	Q3 2025 Reduced 93.93%
NRIX Nurix Therapeutics, Inc.	$580M	$0 0.0% of portfolio	27	Q3 2025 Reduced 51.79%
NVCT Nuvectis Pharma, Inc.	$89.9M	$0 0.0% of portfolio	35	Q3 2025 New
OVID Ovid Therapeutics Inc.	$90.1M	$0 0.0% of portfolio	23	Q3 2025 Reduced 98.47%
PASG Passage Bio, Inc.	$339M	$0 0.0% of portfolio	1	Q3 2025 Reduced 80.0%
PMCB Pharma Cyte Biotech, Inc.	$17.6M	$0 0.0% of portfolio	1	Q2 2024 Reduced 99.9%
PLX Protalix Bio Therapeutics, Inc.	$109M	$0 0.0% of portfolio	163	Q3 2025 New
TARA Protara Therapeutics, Inc.	$48.3M	$0 0.0% of portfolio	42	Q3 2025 New
STTK Shattuck Labs, Inc.	$82.6M	$0 0.0% of portfolio	127	Q3 2025 Reduced 95.75%
TCRX T Scan Therapeutics, Inc.	$20.4M	$0 0.0% of portfolio	8	Q3 2025 Reduced 98.61%
VRCA Verrica Pharmaceuticals Inc.	$327M	$0 0.0% of portfolio	28	Q3 2025 Reduced 99.23%
VERU Veru Inc.	$205M	$0 0.0% of portfolio	2	Q3 2025 Reduced 99.92%
WVE Wave Life Sciences Ltd.	$644M	$0 0.0% of portfolio	31	Q2 2025 Added 3.33%
AADI Aadi Bioscience, Inc.	$35.9M	$0 0.0% of portfolio	25	Q3 2024 Reduced 84.47%
XBIT X Biotech Inc.	$69.1M	$0 0.0% of portfolio	127	Q3 2025 Reduced 78.87%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.